Assessment of community support for Wolbachia-mediated population suppression as a control method for Aedes aegypti mosquitoes in a community cohort in Puerto Rico
- PMID: 34871301
- PMCID: PMC8675917
- DOI: 10.1371/journal.pntd.0009966
Assessment of community support for Wolbachia-mediated population suppression as a control method for Aedes aegypti mosquitoes in a community cohort in Puerto Rico
Abstract
Arboviral diseases transmitted by Aedes species mosquitoes pose an increasing public health challenge in tropical regions. Wolbachia-mediated population suppression (Wolbachia suppression) is a vector control method used to reduce Aedes mosquito populations by introducing male mosquitoes infected with Wolbachia, a naturally occurring endosymbiotic bacterium. When Wolbachia-infected male mosquitoes mate with female wild mosquitoes, the resulting eggs will not hatch. Public support is vital to the successful implementation and sustainability of vector control interventions. Communities Organized to Prevent Arboviruses (COPA) is a cohort study to determine the incidence of arboviral disease in Ponce, Puerto Rico and evaluate vector control methods. Focus groups were conducted with residents of COPA communities to gather their opinion on vector control methods; during 2018-2019, adult COPA participants were interviewed regarding their views on Wolbachia suppression; and a follow-up questionnaire was conducted among a subset of participants and non-participants residing in COPA communities. We analyzed factors associated with support for this method. Among 1,528 participants in the baseline survey, median age was 37 years and 63% were female. A total of 1,032 (68%) respondents supported Wolbachia suppression. Respondents with an income of $40,000 or more were 1.34 times as likely [95% CI: 1.03, 1.37] to support Wolbachia suppression than those who earned less than $40,000 annually. Respondents who reported repellant use were 1.19 times as likely to support Wolbachia suppression [95% CI: 1.03, 1.37]. A follow-up survey in 2020 showed that most COPA participants (86%) and non-participants living in COPA communities (84%) supported Wolbachia suppression during and after an educational campaign. The most frequent questions regarding this method were related to its impact on human and animal health, and the environment. Continuous community engagement and education efforts before and during the implementation of novel vector control interventions are necessary to increase and maintain community support.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Incompatible Aedes aegypti male releases as an intervention to reduce mosquito population-A field trial in Puerto Rico.PLoS Negl Trop Dis. 2025 Jan 21;19(1):e0012839. doi: 10.1371/journal.pntd.0012839. eCollection 2025 Jan. PLoS Negl Trop Dis. 2025. PMID: 39836703 Free PMC article.
-
Efficient production of male Wolbachia-infected Aedes aegypti mosquitoes enables large-scale suppression of wild populations.Nat Biotechnol. 2020 Apr;38(4):482-492. doi: 10.1038/s41587-020-0471-x. Epub 2020 Apr 6. Nat Biotechnol. 2020. PMID: 32265562
-
Effectiveness of Wolbachia-infected mosquito deployments in reducing the incidence of dengue and other Aedes-borne diseases in Niterói, Brazil: A quasi-experimental study.PLoS Negl Trop Dis. 2021 Jul 12;15(7):e0009556. doi: 10.1371/journal.pntd.0009556. eCollection 2021 Jul. PLoS Negl Trop Dis. 2021. PMID: 34252106 Free PMC article.
-
Designing effective Wolbachia release programs for mosquito and arbovirus control.Acta Trop. 2021 Oct;222:106045. doi: 10.1016/j.actatropica.2021.106045. Epub 2021 Jul 15. Acta Trop. 2021. PMID: 34273308 Review.
-
Wolbachia-mediated virus blocking in the mosquito vector Aedes aegypti.Curr Opin Insect Sci. 2017 Aug;22:37-44. doi: 10.1016/j.cois.2017.05.005. Epub 2017 May 10. Curr Opin Insect Sci. 2017. PMID: 28805637 Review.
Cited by
-
Comparison of the sensitivity and specificity of commercial anti-dengue virus IgG tests to identify persons eligible for dengue vaccination.J Clin Microbiol. 2024 Oct 16;62(10):e0059324. doi: 10.1128/jcm.00593-24. Epub 2024 Aug 28. J Clin Microbiol. 2024. PMID: 39194193 Free PMC article.
-
Mosquito and global dengue cases in a warming world.BMJ Glob Health. 2025 May 6;10(5):e014688. doi: 10.1136/bmjgh-2023-014688. BMJ Glob Health. 2025. PMID: 40335075 Free PMC article.
-
Symbiotic Wolbachia in mosquitoes and its role in reducing the transmission of mosquito-borne diseases: updates and prospects.Front Microbiol. 2023 Oct 13;14:1267832. doi: 10.3389/fmicb.2023.1267832. eCollection 2023. Front Microbiol. 2023. PMID: 37901801 Free PMC article. Review.
-
Comparison of the Sensitivity and Specificity of Commercial Anti-Dengue Virus IgG Tests to Identify Persons Eligible for Dengue Vaccination.medRxiv [Preprint]. 2024 Apr 20:2024.04.19.24306097. doi: 10.1101/2024.04.19.24306097. medRxiv. 2024. Update in: J Clin Microbiol. 2024 Oct 16;62(10):e0059324. doi: 10.1128/jcm.00593-24. PMID: 38712100 Free PMC article. Updated. Preprint.
-
Exploring 97 Years of Aedes aegypti as the Vector for Dengue, Yellow Fever, Zika, and Chikungunya (Diptera: Culicidae): Scientometric Analysis.Interact J Med Res. 2025 Apr 23;14:e65844. doi: 10.2196/65844. Interact J Med Res. 2025. PMID: 40267478 Free PMC article.
References
-
- Stanaway JD, Shepard DS, Undurraga EA, Halasa YA, Coffeng LE, Brady OJ, et al.. The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016;16(6):712–23. Epub 2016/02/15. doi: 10.1016/S1473-3099(16)00026-8 ; PubMed Central PMCID: PMC5012511. - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources